 Benjamin Kopecky
Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 11 | 2024 | 1484 | 1.830 |
Why?
| | Ear, Inner | 5 | 2013 | 45 | 1.280 |
Why?
| | Heart Transplantation | 4 | 2023 | 721 | 1.190 |
Why?
| | Organ of Corti | 7 | 2013 | 14 | 1.170 |
Why?
| | Graft Rejection | 6 | 2024 | 598 | 1.070 |
Why?
| | Organ Transplantation | 2 | 2024 | 228 | 0.880 |
Why?
| | Transplantation Tolerance | 1 | 2024 | 35 | 0.870 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2013 | 131 | 0.740 |
Why?
| | Hair Cells, Auditory | 6 | 2013 | 41 | 0.710 |
Why?
| | Myocardium | 4 | 2024 | 978 | 0.700 |
Why?
| | Precision Medicine | 1 | 2024 | 386 | 0.670 |
Why?
| | Microscopy, Confocal | 4 | 2013 | 305 | 0.650 |
Why?
| | Monocytes | 5 | 2024 | 551 | 0.580 |
Why?
| | Cell Differentiation | 6 | 2024 | 1887 | 0.570 |
Why?
| | Lung Transplantation | 1 | 2020 | 289 | 0.540 |
Why?
| | Cochlea | 4 | 2013 | 100 | 0.480 |
Why?
| | Mice | 21 | 2024 | 16915 | 0.460 |
Why?
| | Genes, myc | 2 | 2012 | 49 | 0.450 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 6 | 2020 | 235 | 0.440 |
Why?
| | Animals | 27 | 2024 | 35309 | 0.430 |
Why?
| | Hair Cells, Auditory, Inner | 2 | 2013 | 14 | 0.430 |
Why?
| | Ear | 3 | 2015 | 31 | 0.410 |
Why?
| | Calcium Channel Blockers | 1 | 2014 | 161 | 0.410 |
Why?
| | Neuroprotective Agents | 1 | 2014 | 122 | 0.410 |
Why?
| | Calcium Channels, T-Type | 1 | 2014 | 94 | 0.390 |
Why?
| | Gait Ataxia | 1 | 2012 | 4 | 0.390 |
Why?
| | Regeneration | 2 | 2013 | 181 | 0.380 |
Why?
| | Vestibular Diseases | 1 | 2012 | 25 | 0.380 |
Why?
| | Vestibule, Labyrinth | 1 | 2012 | 66 | 0.360 |
Why?
| | Nervous System Diseases | 1 | 2014 | 252 | 0.360 |
Why?
| | Epithelium | 2 | 2011 | 311 | 0.350 |
Why?
| | Gene Deletion | 2 | 2011 | 380 | 0.340 |
Why?
| | Sensory Receptor Cells | 1 | 2011 | 103 | 0.340 |
Why?
| | Cerebellum | 1 | 2012 | 218 | 0.330 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 529 | 0.310 |
Why?
| | Heart | 3 | 2023 | 637 | 0.310 |
Why?
| | Mice, Knockout | 7 | 2024 | 2871 | 0.300 |
Why?
| | Tissue Donors | 2 | 2022 | 391 | 0.300 |
Why?
| | Cell Proliferation | 2 | 2013 | 2375 | 0.290 |
Why?
| | Hair Cells, Auditory, Outer | 2 | 2020 | 6 | 0.290 |
Why?
| | Homeostasis | 2 | 2023 | 605 | 0.280 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5439 | 0.250 |
Why?
| | Positron-Emission Tomography | 2 | 2024 | 286 | 0.230 |
Why?
| | Arginase | 1 | 2024 | 32 | 0.230 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2024 | 60 | 0.220 |
Why?
| | In Situ Hybridization | 3 | 2013 | 296 | 0.220 |
Why?
| | Signal Transduction | 4 | 2024 | 4926 | 0.220 |
Why?
| | Ventricular Remodeling | 2 | 2024 | 255 | 0.210 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2024 | 132 | 0.200 |
Why?
| | Cell Communication | 1 | 2024 | 300 | 0.200 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 274 | 0.200 |
Why?
| | Myocardial Reperfusion Injury | 2 | 2024 | 129 | 0.200 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 276 | 0.200 |
Why?
| | Adipose Tissue, White | 1 | 2022 | 37 | 0.200 |
Why?
| | Interferon Type I | 1 | 2023 | 139 | 0.200 |
Why?
| | Cyclosporine | 1 | 2023 | 263 | 0.190 |
Why?
| | PAX2 Transcription Factor | 2 | 2013 | 6 | 0.190 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2025 | 231 | 0.190 |
Why?
| | Receptors, Cell Surface | 1 | 2024 | 380 | 0.190 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2022 | 96 | 0.190 |
Why?
| | Antigens, CD | 1 | 2024 | 489 | 0.180 |
Why?
| | Graft Survival | 1 | 2024 | 511 | 0.180 |
Why?
| | Immunity, Innate | 2 | 2024 | 803 | 0.180 |
Why?
| | Integrases | 2 | 2013 | 119 | 0.180 |
Why?
| | Hearing Loss | 3 | 2015 | 210 | 0.170 |
Why?
| | Myocardial Infarction | 2 | 2024 | 1021 | 0.170 |
Why?
| | Macrophage Activation | 1 | 2021 | 189 | 0.170 |
Why?
| | LIM Domain Proteins | 1 | 2020 | 17 | 0.170 |
Why?
| | Humans | 19 | 2025 | 129266 | 0.170 |
Why?
| | LIM-Homeodomain Proteins | 1 | 2020 | 13 | 0.170 |
Why?
| | Immunohistochemistry | 3 | 2013 | 1691 | 0.170 |
Why?
| | Atherosclerosis | 1 | 2024 | 402 | 0.160 |
Why?
| | Gait | 2 | 2013 | 278 | 0.160 |
Why?
| | Fibroblasts | 1 | 2024 | 948 | 0.160 |
Why?
| | Nerve Tissue Proteins | 3 | 2012 | 569 | 0.160 |
Why?
| | Immunosuppressive Agents | 1 | 2024 | 854 | 0.150 |
Why?
| | Antioxidants | 1 | 2022 | 558 | 0.150 |
Why?
| | Phenotype | 2 | 2024 | 3074 | 0.150 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2021 | 381 | 0.140 |
Why?
| | Neovascularization, Physiologic | 1 | 2018 | 175 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 399 | 0.130 |
Why?
| | Hearing | 2 | 2015 | 134 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2022 | 671 | 0.120 |
Why?
| | Embryo, Mammalian | 2 | 2012 | 224 | 0.120 |
Why?
| | Morpholines | 1 | 2015 | 122 | 0.110 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 499 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2012 | 820 | 0.110 |
Why?
| | Hypertension, Pulmonary | 1 | 2025 | 1894 | 0.100 |
Why?
| | Cell Lineage | 2 | 2024 | 332 | 0.100 |
Why?
| | Vertebrates | 1 | 2013 | 58 | 0.100 |
Why?
| | Phenylurea Compounds | 1 | 2013 | 89 | 0.100 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2013 | 51 | 0.100 |
Why?
| | Receptors, CCR2 | 2 | 2024 | 39 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2015 | 605 | 0.090 |
Why?
| | Transcription Factors | 1 | 2020 | 1647 | 0.090 |
Why?
| | Heart Failure | 1 | 2024 | 2135 | 0.090 |
Why?
| | Acoustic Stimulation | 1 | 2013 | 328 | 0.090 |
Why?
| | Cochlear Duct | 1 | 2011 | 1 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 158 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 947 | 0.090 |
Why?
| | Genotype | 2 | 2013 | 1835 | 0.090 |
Why?
| | Organ Specificity | 1 | 2011 | 295 | 0.090 |
Why?
| | Mice, Mutant Strains | 2 | 2021 | 297 | 0.080 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 161 | 0.080 |
Why?
| | Biological Evolution | 1 | 2013 | 432 | 0.080 |
Why?
| | Neoplasms | 1 | 2023 | 2449 | 0.080 |
Why?
| | Quality of Life | 1 | 2020 | 2687 | 0.070 |
Why?
| | Cell Cycle | 1 | 2011 | 589 | 0.070 |
Why?
| | Stem Cell Transplantation | 1 | 2008 | 164 | 0.070 |
Why?
| | Computer Simulation | 1 | 2011 | 939 | 0.070 |
Why?
| | Stem Cells | 1 | 2011 | 574 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 2003 | 0.060 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2020 | 38 | 0.060 |
Why?
| | Genetic Therapy | 1 | 2008 | 288 | 0.060 |
Why?
| | Time Factors | 2 | 2013 | 6543 | 0.060 |
Why?
| | Epitope Mapping | 1 | 2024 | 57 | 0.060 |
Why?
| | Copper Radioisotopes | 1 | 2024 | 1 | 0.060 |
Why?
| | Endopeptidases | 1 | 2024 | 86 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4057 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2015 | 2054 | 0.060 |
Why?
| | Serine Endopeptidases | 1 | 2024 | 118 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2024 | 315 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2024 | 235 | 0.050 |
Why?
| | Cell Adhesion Molecules | 1 | 2024 | 173 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2024 | 168 | 0.050 |
Why?
| | Myofibroblasts | 1 | 2024 | 121 | 0.050 |
Why?
| | Male | 6 | 2025 | 63512 | 0.050 |
Why?
| | Mutation | 3 | 2021 | 3710 | 0.050 |
Why?
| | Starch | 1 | 2022 | 22 | 0.050 |
Why?
| | Interleukin-1beta | 1 | 2024 | 372 | 0.050 |
Why?
| | Transplantation, Homologous | 1 | 2023 | 400 | 0.050 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2022 | 22 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 275 | 0.050 |
Why?
| | Fibrosis | 1 | 2024 | 520 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 89 | 0.050 |
Why?
| | Troponin T | 1 | 2021 | 57 | 0.050 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 207 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2022 | 239 | 0.040 |
Why?
| | Adipocytes | 1 | 2022 | 204 | 0.040 |
Why?
| | Chromatin | 1 | 2024 | 478 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 198 | 0.040 |
Why?
| | Female | 6 | 2025 | 68551 | 0.040 |
Why?
| | Sulfonamides | 1 | 2023 | 495 | 0.040 |
Why?
| | Fatty Acids | 1 | 2022 | 427 | 0.040 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 57 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 631 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 1965 | 0.040 |
Why?
| | Molecular Imaging | 1 | 2019 | 55 | 0.040 |
Why?
| | Stroke Volume | 1 | 2022 | 592 | 0.040 |
Why?
| | Cell Survival | 2 | 2012 | 1075 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2013 | 464 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2022 | 527 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2024 | 1117 | 0.040 |
Why?
| | Mitochondria | 1 | 2022 | 877 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2015 | 52 | 0.030 |
Why?
| | Neuregulin-1 | 1 | 2015 | 46 | 0.030 |
Why?
| | Electrophysiology | 1 | 2015 | 210 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2015 | 193 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 944 | 0.030 |
Why?
| | Spiral Ganglion | 1 | 2013 | 2 | 0.030 |
Why?
| | Developmental Biology | 1 | 2013 | 22 | 0.030 |
Why?
| | Transcription Factor Brn-3C | 1 | 2012 | 1 | 0.020 |
Why?
| | Stereocilia | 1 | 2012 | 8 | 0.020 |
Why?
| | Genes, Lethal | 1 | 2012 | 29 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2012 | 53 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 385 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2012 | 196 | 0.020 |
Why?
| | Organogenesis | 1 | 2012 | 56 | 0.020 |
Why?
| | Myosins | 1 | 2012 | 133 | 0.020 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 2010 | 23 | 0.020 |
Why?
| | Zebrafish | 1 | 2015 | 458 | 0.020 |
Why?
| | GATA3 Transcription Factor | 1 | 2010 | 25 | 0.020 |
Why?
| | Mechanotransduction, Cellular | 1 | 2012 | 111 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 834 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2879 | 0.020 |
Why?
| | Phylogeny | 1 | 2013 | 849 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2012 | 406 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 495 | 0.020 |
Why?
| | Alleles | 1 | 2010 | 845 | 0.020 |
Why?
| | Adult Stem Cells | 1 | 2008 | 39 | 0.020 |
Why?
| | Ethics, Medical | 1 | 2008 | 78 | 0.020 |
Why?
| | Embryonic Stem Cells | 1 | 2008 | 114 | 0.020 |
Why?
| | Pluripotent Stem Cells | 1 | 2008 | 77 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 1049 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2117 | 0.020 |
Why?
| | Cochlear Implants | 1 | 2008 | 104 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2022 | 14461 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4077 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2342 | 0.010 |
Why?
| | Pregnancy | 1 | 2012 | 6390 | 0.010 |
Why?
|
|
Kopecky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|